These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17353290)

  • 1. Murine aerosol challenge model of anthrax.
    Loving CL; Kennett M; Lee GM; Grippe VK; Merkel TJ
    Infect Immun; 2007 Jun; 75(6):2689-98. PubMed ID: 17353290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection.
    Cote CK; Van Rooijen N; Welkos SL
    Infect Immun; 2006 Jan; 74(1):469-80. PubMed ID: 16369003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine response to infection with Bacillus anthracis spores.
    Pickering AK; Osorio M; Lee GM; Grippe VK; Bray M; Merkel TJ
    Infect Immun; 2004 Nov; 72(11):6382-9. PubMed ID: 15501768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores.
    Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA
    PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis.
    Bozue J; Cote CK; Moody KL; Welkos SL
    Infect Immun; 2007 Jan; 75(1):508-11. PubMed ID: 17074844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A; Midha S; Bhatnagar R
    Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
    Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA
    PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells.
    Shetron-Rama LM; Herring-Palmer AC; Huffnagle GB; Hanna P
    Microb Pathog; 2010; 49(1-2):38-46. PubMed ID: 20188814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent evolution of diverse Bacillus anthracis outbreak strains toward altered surface oligosaccharides that modulate anthrax pathogenesis.
    Norris MH; Kirpich A; Bluhm AP; Zincke D; Hadfield T; Ponciano JM; Blackburn JK
    PLoS Biol; 2020 Dec; 18(12):e3001052. PubMed ID: 33370274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax.
    Gold JA; Hoshino Y; Jones MB; Hoshino S; Nolan A; Weiden MD
    PLoS One; 2007 Aug; 2(8):e736. PubMed ID: 17710136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis: interactions with the host and establishment of inhalational anthrax.
    Passalacqua KD; Bergman NH
    Future Microbiol; 2006 Dec; 1(4):397-415. PubMed ID: 17661631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J; Yu F; Cease KB
    J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Jan; 4(1):53-69. PubMed ID: 3143893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and novel strategies in vaccine development and treatment of anthrax.
    Chitlaru T; Altboum Z; Reuveny S; Shafferman A
    Immunol Rev; 2011 Jan; 239(1):221-36. PubMed ID: 21198675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model.
    Barnewall RE; Comer JE; Miller BD; Gutting BW; Wolfe DN; Director-Myska AE; Nichols TL; Taft SC
    Front Cell Infect Microbiol; 2012; 2():71. PubMed ID: 22919662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.
    Yee SB; Dyer DN; Twenhafel NA; Pitt ML
    Comp Med; 2013 Jun; 63(3):252-61. PubMed ID: 23759528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.
    Gutting BW; Marchette D; Sherwood R; Andrews GA; Director-Myska A; Channel SR; Wolfe D; Berger AE; Mackie RS; Watson BJ; Rukhin A
    J Theor Biol; 2013 Jul; 329():20-31. PubMed ID: 23567649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.